FDA Biologics Center Performance To Be Reviewed By Advisory Committees
The Center for Biologics Evaluation & Research will use its advisory committees to perform an external review of its operations
You may also be interested in...
FDA's proposed oncology therapeutics office will be organized into three divisions, Center for Drug Evaluation & Research Medical Policy Director Robert Temple, MD, said June 17 during a Drug Information Association meeting in Washington, D.C
The Center for Biologics Evaluation & Research is developing review templates in an effort to improve product reviews
The House Energy & Commerce Committee and White House funding compromise for Project BioShield could serve as a template for agreement in the Senate